Assertio Holdings Inc (ASRT)
1.07
+0.05
(+4.90%)
USD |
NASDAQ |
May 17, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Assertio Holdings Total Return Level: 1.07 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 1.07 |
May 16, 2024 | 1.02 |
May 15, 2024 | 1.01 |
May 14, 2024 | 1.01 |
May 13, 2024 | 1.05 |
May 10, 2024 | 0.96 |
May 09, 2024 | 1.05 |
May 08, 2024 | 1.055 |
May 07, 2024 | 1.11 |
May 06, 2024 | 1.22 |
May 03, 2024 | 1.03 |
May 02, 2024 | 1.01 |
May 01, 2024 | 0.9212 |
April 30, 2024 | 0.8851 |
April 29, 2024 | 0.848 |
April 26, 2024 | 0.8282 |
April 25, 2024 | 0.7851 |
April 24, 2024 | 0.8656 |
April 23, 2024 | 0.9095 |
April 22, 2024 | 0.8653 |
April 19, 2024 | 0.773 |
April 18, 2024 | 0.754 |
April 17, 2024 | 0.78 |
April 16, 2024 | 0.7957 |
April 15, 2024 | 0.8144 |
Date | Value |
---|---|
April 12, 2024 | 0.8682 |
April 11, 2024 | 0.8823 |
April 10, 2024 | 0.8977 |
April 09, 2024 | 0.9072 |
April 08, 2024 | 0.9228 |
April 05, 2024 | 0.9478 |
April 04, 2024 | 0.9232 |
April 03, 2024 | 0.9243 |
April 02, 2024 | 0.9295 |
April 01, 2024 | 0.9359 |
March 28, 2024 | 0.9593 |
March 27, 2024 | 0.99 |
March 26, 2024 | 1.02 |
March 25, 2024 | 1.04 |
March 22, 2024 | 1.04 |
March 21, 2024 | 1.05 |
March 20, 2024 | 1.04 |
March 19, 2024 | 1.01 |
March 18, 2024 | 1.04 |
March 15, 2024 | 1.12 |
March 14, 2024 | 1.09 |
March 13, 2024 | 1.14 |
March 12, 2024 | 1.01 |
March 11, 2024 | 0.9347 |
March 08, 2024 | 0.9117 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.754
Minimum
Apr 18 2024
13.84
Maximum
May 20 2019
3.428
Average
2.856
Median
Oct 19 2020
Total Return Level Benchmarks
Ocular Therapeutix Inc | 6.17 |
Vertex Pharmaceuticals Inc | 445.21 |
Cormedix Inc | 5.12 |
Verastem Inc | 11.50 |
CytomX Therapeutics Inc | 1.89 |